European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses.
European study on dose response of acarbose as the first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses.